ARCHIVES

ASCO President Swain: “Shattering Impact on Cancer Enterprise”

This article is from The Cancer Letter archive.

Vol. 39 No. 07 | February 15, 2013

Download PDF Visit The Full Archive

Related Articles

DRCCA Board Okays Four Concepts, Rejects One, Tables Two Others

May 27, 1983

Oral Capecitabine Equal To 5FU-Leucovorin In Adjuvant Stage III Colon Cancer Treatment

June 25, 2004

SEER Program Expansion Through Cost-Sharing.

March 23, 2001

Agencies Plan Better Reporting Of Adverse Events In Trials.

February 4, 2000

CDC Study Finds No Correlation Between Alcohol, Breast Cancer

April 8, 1988

In Brief: Senate Health Subcommittee Lineup Completed; GAO Calls For More Ionizing Radiation Studies

January 23, 1981